IP Library › Granted Patent US 11,845,942
Granted Patent B2
US 11,845,942 · App. 16/620,614 · Granted Dec 19, 2023

Compositions and methods for genome editing

Inventor: John Lindbo (Woodland, CA)
Assignee: Vilmorin & Cie
C12N15/8213C12N9/22C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,845,942
App. No.
16/620,614
Granted
Dec 19, 2023
Kind
B2
Abstract

The present disclosure provides compositions, methods, and systems for targeted plant genome editing. In some embodiments, the present disclosure provides recombinant self-replicating RNAs derived from a plant virus vector, such as those derived from Tobacco Mosaic Virus (TMV). In some embodiments, the recombinant self-replicating RNAs direct the expression of both a CRISPR endonuclease and a guide RNA capable of directing sequence-specific binding of the CRISPR endonuclease to a target DNA in the genome of plant cell.

Claims (39)

1. A recombinant self-replicating RNA encoding at least

i) a replicase capable of transcribing the recombinant self-replicating RNA wherein said replicase comprises a polypeptide having at least 90% sequence identity to SEQ ID No. 71;

ii) a clustered regularly interspaced short palindromic repeats (CRISPR) endonuclease, which is a Type II Cas9 endonuclease or a Type V Cpf1 endonuclease; and

iii) at least one guide RNA;

wherein said at least one guide RNA is capable of directing sequence-specific binding of the CRISPR endonuclease to a target DNA.

2. The recombinant self-replicating RNA of claim 1 , further encoding

iv) a movement protein facilitating intercellular movement of the RNA.

3. The recombinant self-replicating RNA of claim 1 , wherein the CRISPR endonuclease is a Type II Cas9 endonuclease.

4. The recombinant self-replicating RNA of claim 1 , wherein the guide RNA has one or more additional nucleotides at its 5′ and/or at its 3′ end.

5. The recombinant self-replicating RNA of claim 4 , wherein said additional nucleotides can comprise up to 1500 nucleotides.

6. The recombinant self-replicating RNA of claim 1 , wherein the self-replicating RNA is derived from the genome of Tobacco Mosaic Virus (TMV).

7. A DNA vector comprising a polynucleotide encoding a recombinant self-replicating RNA, wherein said recombinant self-replicating RNA encodes at least:

i) a replicase capable of transcribing the recombinant self-replicating RNA wherein said replicase comprises a polypeptide having at least 90% sequence identity to SEQ ID No. 71;

ii) a clustered regularly interspaced short palindromic repeats (CRISPR) endonuclease, which is a Type II Cas9 endonuclease or a Type V Cpf1 endonuclease; and

iii) at least one guide RNA;

wherein said at least one guide RNA is capable of directing sequence-specific binding of the CRISPR endonuclease to a target DNA.

8. A method for editing the genome of a plant, said method comprising the steps of:

a) introducing into a cell of the plant at least one recombinant self-replicating RNA, wherein said recombinant self-replicating RNA encodes at least

i) a replicase capable of transcribing the recombinant self-replicating RNA, wherein said replicase comprises a polypeptide having at least 90% sequence identity to SEQ ID No. 71;

ii) a clustered regularly interspaced short palindromic repeats (CRISPR) endonuclease, which is a Type II Cas9 endonuclease or a Type V Cpf1 endonuclease; and

iii) at least one guide RNA,

wherein said at least one guide RNA is capable of directing sequence-specific binding of the CRISPR endonuclease to a target DNA;

wherein elements (i), (ii), and (iii) are expressed in the cell, and the CRISPR endonuclease cleaves the cell's genome at the target DNA, thereby editing the plant genome.

9. The method of claim 8 , said method comprising: introducing into the cell of the plant, a DNA vector comprising a polynucleotide encoding the recombinant self-replicating RNA.

10. The method claim 8 , wherein the CRISPR endonuclease is a Type II Cas9 endonuclease.

11. The method of claim 8 , wherein the introducing step comprises a step selected from the group consisting of:

i) agroinfiltrating a DNA vector comprising a polynucleotide encoding the recombinant self-replicating RNA, into the plant cell;

ii) contacting the recombinant self-replicating RNA or a DNA vector comprising a polynucleotide encoding the recombinant self-replicating RNA, with the plant cell;

iii) electroporating the recombinant self-replicating RNA, or a DNA vector comprising a polynucleotide encoding said recombinant self-replicating RNA, into the plant cell,

iv) mechanical inoculation and/or

v) biolistically delivering the recombinant self-replicating RNA, or a DNA vector comprising a polynucleotide encoding said recombinant self-replicating RNA, into the plant cell.

12. The method of claim 8 , further comprising step b) screening the cell of the plant for the presence of a mutation in the target DNA of the plant cell genome.

13. The method of claim 12 , further comprising step c) regenerating the plant cell comprising the mutation identified in step b).

14. A composition comprising at least one recombinant self-replicating RNA of claim 1 .

15. A composition comprising the DNA vector of claim 7 .

16. A cell comprising the recombinant self-replicating RNA of claim 1 .

17. A cell comprising the DNA vector of claim 7 .

18. The recombinant self-replicating RNA of claim 1 , wherein the CRISPR endonuclease is a Type V Cpf1 endonuclease.

19. The method of claim 8 , wherein the CRISPR endonuclease is a Type V Cpf1 endonuclease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2019
From: LINDBO, JOHN
To: VILMORIN & CIE
Reel/Frame 051233/0360 →
Continuity (2)
Provisional Application 62517360 · Jun 9, 2017
Related Publication 20200199605A1 · Jun 25, 2020
Cited By (2)
US 12,351,811 US 12,529,067